Orchestra BioMed Holdings, Inc. director Eric S Fain picks up 20,000 shares worth $100,000
The director paid an average of $5.00 a share, according to a Form 4 filed with the SEC on Nov 9.
Eric S Fain purchased about $100,000 of Orchestra BioMed Holdings, Inc. (OBIO) stock on Nov 9, according to an SEC filing. The director paid an average of $5.00 for 20,000 shares.
The purchase was made in the open market, not through an award, an option exercise or a plan. Other Orchestra BioMed Holdings, Inc. insiders have also bought: Four insiders made open-market purchases within 14 days, a pattern known as a cluster buy.
It is the sixth insider purchase at Orchestra BioMed Holdings, Inc. reported in the last 90 days. The purchase raises the insider's holding by 20%, to 119,630 shares.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Orchestra BioMed Holdings, Inc. (OBIO) |
|---|---|
| Insider | Eric S Fain |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 20,000 |
| Average price | $5.00 |
| Value | $100,000 |
| Trade date | Nov 9, 2026 |
| Filed with the SEC | Nov 9, 2026, 4:32 PM ET |
| Shares held after | 119,630 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider purchase
Read the daily insider trading roundup · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.